Clinical Trials Directory

Trials / Unknown

UnknownNCT03140319

Transplantation of Fibroblast for Correction of Nasolabial Folds

Autologous Transplantation of Cultured Fibroblast for Correction of Nasolabial Folds

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
SCARM Institute, Tabriz, Iran · Other Government
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study evaluated the safety and efficacy of the Autologous cultured fibroblast for correction of Nasolabial folds and inhibition of skin aging

Detailed description

Autologous cultured fibroblast which is obtain from the patient's normal skin is harvested and expanded in an in vitro. Biopsies samples are obtained from the behind of the patient's ear as a source of fibroblasts, then fibroblast cells isolated and expanded through cell culture, and used for the correction of Nasolabial folds, deep wrinkles of the forehead. Prior to final packaging, cell viability is assessed to be at least 85%

Conditions

Interventions

TypeNameDescription
BIOLOGICALFibroblastTransplantation of 20 million cell by three injection
BIOLOGICALPlaceboInjection of Placebo

Timeline

Start date
2020-12-10
Primary completion
2021-11-15
Completion
2021-12-26
First posted
2017-05-04
Last updated
2020-10-27

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT03140319. Inclusion in this directory is not an endorsement.